However, our comparison of two Tg PC models, Pten/Rb-null vs. Akap12/Rb-null, which share similar levels of Akt activation plus Rb loss, yet which have different outcomes in regard to primary PC and mPC progression, strongly suggests that “AKT activation” alone is insufficient to explain these differences. This evidence concerns the gene AKT1 and pachyonychia congenita.